CDMO  valuation analysis

Name: Avid Bioservices Inc
Description: Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Mar 08, 2022
Market cap: $803.51M (1274th)
Sales(TTM): $115.98M (1394th)
Earnings(TTM): $14.06M (1213th)

FFER: 0.78*
Actual price: $12.58
* Earnings were reported Sep 06, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Avid Bioservices Inc
"Biotechnology" industry
Sales / MarketCap
Avid Bioservices Inc
"Biotechnology" industry
Book / MarketCap
Avid Bioservices Inc
"Biotechnology" industry
Equity / Assets
Avid Bioservices Inc
"Biotechnology" industry